Journal Article
. 2015 May; 8(2):1503-14.

Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma

Nermeen S Youssef 1 Wesam M Osman 1 
Affiliations
  • PMID: 25973035
  •     49 References
  •     4 citations

Abstract

Previous studies on the prognostic value of osteopontin (OPN) and β-catenin in colorectal carcinoma (CRC) revealed conflicting results. To date, only two immunohistochemical studies investigated their association in CRC with discrepant results. Moreover, the relevance of their co-expression to clinicopathological parameters was not previously reported. This study was designed to investigate the relationship between these markers and prognostic parameters in CRC and study further the relationship between them. Immunohistochemical expression of OPN and β-catenin was evaluated in 72 CRCs. Cytoplasmic OPN was detected in 45.83% of CRCs while normal mucosa was immunonegative. Strong continuous membranous β-catenin was present in normal mucosa. However, abnormal membranous, nuclear and cytoplasmic expressions were observed in 36.11%, 31.94% and 52.78% of CRCs, respectively. A highly significant relationship was detected between each of OPN and nuclear β-catenin expression and lymph node metastasis (P = 0.0001 and 0.004 respectively), depth of invasion (P = 0.001 and 0.004 respectively), TNM stages (P = 0.0001 and 0.001 respectively) and Dukes' stages (P = 0.0001 and 0.004 respectively). A significant association was found between OPN and distant metastases. A strong agreement was observed between OPN and nuclear β-catenin (kappa = 0.656). A highly significant relationship was found between their co-expression and poor prognostic parameters. OPN overexpression and nuclear β-catenin expression appeared to be associated with unfavorable prognostic factors in CRC. A direct relationship was observed between them. Further understanding their role in colorectal carcinogenesis as well as targeting the interaction between them might be effective in the future development of therapeutic agents for CRC patients.

Keywords: Colorectal carcinoma; immunohistochemistry; osteopontin; β-catenin.

Other Links

Free PMC article 
Osteopontin as a target for cancer therapy.
Nicholas I F Johnston, Vignesh Kumar Gunasekharan, +3 authors, Mohamed K El-Tanani.
Front Biosci, 2008 May 30; 13. PMID: 18508515
Review.
Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.
Aleksandra Stanczak, Rafal Stec, +7 authors, Monika Lamparska-Przybysz.
Pathol Oncol Res, 2011 Jun 17; 17(4). PMID: 21678109    Free PMC article.
Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
Jiasen Cheng, De-Hua Huo, +3 authors, Shi-Mei Zhuang.
Cancer Res, 2007 Jun 05; 67(11). PMID: 17545592
Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.
Deepak Agrawal, Tingan Chen, +6 authors, Timothy J Yeatman.
J Natl Cancer Inst, 2002 Apr 04; 94(7). PMID: 11929952
Highly Cited.
Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.
K Maruyama, A Ochiai, +4 authors, S Hirohashi.
Oncology, 2000 Nov 30; 59(4). PMID: 11096342
β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.
Zhigang Chen, Xin He, +9 authors, Jian Huang.
PLoS One, 2013 May 30; 8(5). PMID: 23717499    Free PMC article.
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
S M Hsu, L Raine, H Fanger.
J Histochem Cytochem, 1981 Apr 01; 29(4). PMID: 6166661
Highly Cited.
Assembly of the cadherin-catenin complex in vitro with recombinant proteins.
H Aberle, S Butz, +3 authors, H Hoschuetzky.
J Cell Sci, 1994 Dec 01; 107 ( Pt 12). PMID: 7706414
Highly Cited.
Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
M Fujimori, S Ikeda, +2 authors, T Asahara.
Cancer Res, 2001 Sep 18; 61(18). PMID: 11559529
Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Jianjin Huang, Chi Pan, +2 authors, Ling Ding.
PLoS One, 2012 Nov 01; 7(10). PMID: 23112867    Free PMC article.
Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
D J Mole, C O'Neill, +6 authors, F C Campbell.
Br J Cancer, 2011 Feb 24; 104(6). PMID: 21343932    Free PMC article.
Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.
Sze Chuen Cesar Wong, Elena Siu Fong Lo, +2 authors, W L Wendy Hsiao.
Clin Cancer Res, 2004 Feb 24; 10(4). PMID: 14977843
Relationship between β-catenin expression and prognostic parameters of colorectal carcinomas.
Kemal Peker, Mahmut Başoğlu, Nesrin Gürsan.
Turk Patoloji Derg, 2013 May 11; 29(2). PMID: 23661344
Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.
D R Senger, C A Perruzzi, A Papadopoulos.
Anticancer Res, 1989 Sep 01; 9(5). PMID: 2686530
Review.
cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN).
M F Young, J M Kerr, +4 authors, L W Fisher.
Genomics, 1990 Aug 01; 7(4). PMID: 1974876
Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.
Chandra M V Goparaju, Harvey I Pass, +2 authors, Jessica S Donington.
J Thorac Oncol, 2010 Aug 07; 5(10). PMID: 20689445    Free PMC article.
A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Peh Yean Cheah, Poh Heok Choo, +2 authors, Francis Seow-Choen.
Cancer, 2002 Dec 06; 95(12). PMID: 12467060
Cancer cell invasion and metastasis.
L A Liotta.
Sci Am, 1992 Feb 01; 266(2). PMID: 1373003
Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
Xiang-Qian Zhao, Jia-Hong Dong, Wen-Zhi Zhang, Zhe Liu.
Diagn Pathol, 2011 Oct 14; 6. PMID: 21992455    Free PMC article.
Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
G G Chung, E Provost, +3 authors, D L Rimm.
Clin Cancer Res, 2001 Dec 26; 7(12). PMID: 11751495
Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer.
Franziska Rohde, Caroline Rimkus, +6 authors, Klaus-Peter Janssen.
Int J Cancer, 2007 Jun 15; 121(8). PMID: 17565744
Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry.
Jing Li, Guang-Zhi Yang, +2 authors, Lin Li.
Exp Ther Med, 2012 Sep 13; 3(4). PMID: 22969940    Free PMC article.
Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.
A I Barth, I S Näthke, W J Nelson.
Curr Opin Cell Biol, 1997 Oct 23; 9(5). PMID: 9330872
Highly Cited. Review.
Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
Tuomo T Hörkkö, Kai Klintrup, +5 authors, Markus J Mäkinen.
Eur J Cancer, 2006 Mar 28; 42(7). PMID: 16563744
Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
Michael G A Norwood, Neil Bailey, +11 authors, Janusz A Jankowski.
Histopathology, 2010 Jun 25; 57(1). PMID: 20572881
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites.
Rebecca L Siegel, Ahmedin Jemal, +2 authors, Elizabeth M Ward.
J Natl Med Assoc, 2008 Dec 30; 100(12). PMID: 19110912
Treatment of liver metastases, an update on the possibilities and results.
T Ruers, R P Bleichrodt.
Eur J Cancer, 2002 Apr 30; 38(7). PMID: 11978527
Review.
Osteopontin and colon cancer progression.
Timothy J Yeatman, Ann F Chambers.
Clin Exp Metastasis, 2003 Mar 26; 20(1). PMID: 12650611
Review.
Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms.
T Mikami, H Mitomi, +4 authors, I Okayasu.
Cancer, 2000 Aug 22; 89(4). PMID: 10951334
Molecular origins of cancer: Molecular basis of colorectal cancer.
Sanford D Markowitz, Monica M Bertagnolli.
N Engl J Med, 2009 Dec 19; 361(25). PMID: 20018966    Free PMC article.
Highly Cited. Review.
Nuclear beta-catenin overexpression in metastatic sentinel lymph node is associated with synchronous liver metastasis in colorectal cancer.
Hongxia Cheng, Hui Liang, Yejun Qin, Ying Liu.
Diagn Pathol, 2011 Nov 08; 6. PMID: 22053859    Free PMC article.
Cancer statistics, 2012.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal.
CA Cancer J Clin, 2012 Jan 13; 62(1). PMID: 22237781
Highly Cited.
Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.
Domenico Coppola, Marianna Szabo, +4 authors, Timothy J Yeatman.
Clin Cancer Res, 2004 Jan 22; 10(1 Pt 1). PMID: 14734468
Highly Cited.
Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients.
Felipe de Sousa E Melo, Selcuk Colak, +16 authors, Jan Paul Medema.
Cell Stem Cell, 2011 Nov 08; 9(5). PMID: 22056143
Highly Cited.
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Sakarias Wangefjord, Jenny Brändstedt, +3 authors, Jakob Eberhard.
Diagn Pathol, 2013 Jan 23; 8. PMID: 23337059    Free PMC article.
Control of the human osteopontin promoter by ERRα in colorectal cancer.
Salah Boudjadi, Gérald Bernatchez, Jean-François Beaulieu, Julie C Carrier.
Am J Pathol, 2013 May 18; 183(1). PMID: 23680656
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer.
K Günther, T Brabletz, +7 authors, W G Ballhausen.
Dis Colon Rectum, 1998 Oct 27; 41(10). PMID: 9788389
Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus.
Maria-Chiara Osterheld, Yan-Song Bian, +2 authors, Charlotte Fontolliet.
Am J Clin Pathol, 2002 Mar 13; 117(3). PMID: 11888085
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Jacques Ferlay, Hai-Rim Shin, +3 authors, Donald Maxwell Parkin.
Int J Cancer, 2011 Feb 26; 127(12). PMID: 21351269
Highly Cited.
Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Hee Sung Kim, Eun Kyung Hong, +2 authors, Hye Seung Lee.
Anticancer Res, 2003 Aug 21; 23(3C). PMID: 12926124
MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
Stephan E Baldus, Stefan P Mönig, +7 authors, Hans P Dienes.
Clin Cancer Res, 2004 Apr 23; 10(8). PMID: 15102686
Wnt signaling and cancer.
P Polakis.
Genes Dev, 2000 Aug 02; 14(15). PMID: 10921899
Highly Cited. Review.
Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells.
D R Senger, C A Perruzzi.
Cancer Res, 1985 Nov 01; 45(11 Pt 2). PMID: 4053052
Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Sang-Jeon Lee, Song Yi Choi, +8 authors, Seon Mee Park.
Diagn Pathol, 2013 Jun 21; 8. PMID: 23783026    Free PMC article.
Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
A Lugli, I Zlobec, +4 authors, J R Jass.
Histopathology, 2007 Apr 24; 50(4). PMID: 17448021
The oncogenic activation of beta-catenin.
P Polakis.
Curr Opin Genet Dev, 1999 Mar 11; 9(1). PMID: 10072352
Highly Cited. Review.
β-Catenin and its relation to VEGF and cyclin D1 expression in pT3 rectosigmoid cancers.
Fatma Hüsniye Dılek, Nevin Topak, +2 authors, Osman Nuri Dılek.
Turk J Gastroenterol, 2011 Feb 19; 21(4). PMID: 21331989
Purification of a 92-kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure.
P D McCrea, B M Gumbiner.
J Biol Chem, 1991 Mar 05; 266(7). PMID: 1999432
Highly Cited.
Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Lidan Sun, Fei Chen, +3 authors, Jianping Zhang.
Diagn Pathol, 2014 Jul 18; 9. PMID: 25029906    Free PMC article.
A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.
Jian-Hong Peng, Yu-Jing Fang, +9 authors, De Sen Wan.
Oncotarget, 2016 Mar 24; 7(16). PMID: 27008710    Free PMC article.
Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression.
Nanhui Yu, Hong Zhu, +7 authors, Haiping Pei.
Onco Targets Ther, 2016 Nov 09; 9. PMID: 27822070    Free PMC article.
Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma: A meta-analysis.
Shizhen Zhang, Zhen Wang, +6 authors, Xiaochen Wang.
Medicine (Baltimore), 2016 Dec 09; 95(49). PMID: 27930552    Free PMC article.
Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications.
Katyana Amilca-Seba, Michèle Sabbah, Annette K Larsen, Jérôme A Denis.
Cancers (Basel), 2021 Aug 08; 13(15). PMID: 34359694    Free PMC article.
Review.